High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?

被引:14
|
作者
Dreischulte, Tobias [1 ]
Guthrie, Bruce [1 ]
机构
[1] Univ Dundee Populat Hlth Sci, Kirsty Semple Way, Dundee, Scotland
关键词
adverse drug event; clinical decision support system; medication error; medication safety; performance feedback; primary healthcare;
D O I
10.1177/2042098612444867
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The safety of medication use in primary care is an area of increasing concern for health systems internationally. Systematic reviews estimate that 3-4% of all unplanned hospital admissions are due to preventable drug-related morbidity, the majority of which have been attributed to shortcomings in the prescribing and monitoring stages of the medication use process. We define high-risk prescribing as medication prescription by professionals, for which there is evidence of significant risk of harm to patients, and which should therefore either be avoided or (if avoidance is not possible) closely monitored and regularly reviewed for continued appropriateness. Although prevalence estimates vary depending on the instrument used, cross-sectional studies conducted in primary care equivocally show that it is common and there is evidence that it can be reduced. Quality improvement strategies, such as clinical decision support, performance feedback and pharmacist-led interventions have been shown to be effective in reducing prescribing outcomes but evidence of improved patient outcomes remains limited. The increasing implementation of electronic medical records in primary care offer new opportunities to combine different strategies to improve medication safety in primary care and to integrate services provided by different stakeholders. In this review article, we describe the spectrum of high-risk medication use in primary care, review approaches to its measurement and summarize research into its prevalence. Based on previously developed interventions to change professional practice, we propose a systematic approach to improve the safety of medication use in primary care and highlight areas for future research.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 50 条
  • [1] How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
    Stanciakova, Lucia
    Dobrotova, Miroslava
    Holly, Pavol
    Zolkova, Jana
    Vadelova, Lubica
    Skornova, Ingrid
    Ivankova, Jela
    Samos, Matej
    Bolek, Tomas
    Grendar, Marian
    Danko, Jan
    Kubisz, Peter
    Stasko, Jan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [2] How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
    Stanciakova, Lucia
    Dobrotova, Miroslava
    Holly, Pavol
    Zolkova, Jana
    Vadelova, Lubica
    Skornova, Ingrid
    Ivankova, Jela
    Samos, Matej
    Bolek, Tomas
    Grendar, Marian
    Danko, Jan
    Kubisz, Peter
    Stasko, Jan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [3] How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
    Stanciakova, Lucia
    Dobrotova, Miroslava
    Holly, Pavol
    Zolkova, Jana
    Vadelova, Lubica
    Skornova, Ingrid
    Ivankova, Jela
    Samos, Matej
    Bolek, Tomas
    Grendar, Marian
    Danko, Jan
    Kubisz, Peter
    Stasko, Jan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [4] How can we improve antibiotic prescribing in primary care?
    Dyar, Oliver J.
    Beovic, Bojana
    Vlahovic-Palcevski, Vera
    Verheij, Theo
    Pulcini, Celine
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (04) : 403 - 413
  • [6] SUPPORTING HIGH QUALITY AND EVIDENCE BASED PRESCRIBING. HOW A FORMULARY CAN INFLUENCE PRESCRIBING PATTERNS IN PRIMARY CARE
    Crookes, D.
    Gilchrist, A.
    Pearson, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 150 - 150
  • [7] How can we identify the high-risk patient?
    Sankar, Ashwin
    Beattie, W. Scott
    Wijeysundera, Duminda N.
    CURRENT OPINION IN CRITICAL CARE, 2015, 21 (04) : 328 - 335
  • [8] High-risk prescribing in an Irish primary care population: trends and variation
    Byrne, Catherine J.
    Cahir, Caitriona
    Curran, Carmel
    Bennett, Kathleen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (12) : 2821 - 2830
  • [9] How can we stamp out high-risk myeloma?
    Banerjee, Rahul
    Mikhael, Joseph R.
    BLOOD, 2024, 143 (20) : 2015 - 2016
  • [10] MEDICAL MONITORING - WHAT IS IT, HOW CAN IT BE IMPROVED
    BEELER, MF
    SAPPENFIELD, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (02) : 285 - 288